Cladribine in the treatment of acute myeloid leukemia: a single-institution experience.

Clinical lymphoma & myeloma

Volumn 9, Issue 4, 2009, Pages 298-301

  Martin, Mike G ^a   Welch, John S ^a   Augustin, Kristan ^a   Hladnik, Lindsay ^a   DiPersio, John F ^a   Abboud, Camille N ^a  

^a WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT; CLADRIBINE;

ACUTE GRANULOCYTIC LEUKEMIA; ADULT; AGED; ARTICLE; FEMALE; HUMAN; MALE; MIDDLE AGED; RECURRENT DISEASE; RETROSPECTIVE STUDY; SALVAGE THERAPY; SUBCUTANEOUS DRUG ADMINISTRATION; TREATMENT OUTCOME;

ADULT; AGED; AGED, 80 AND OVER; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; CLADRIBINE; FEMALE; HUMANS; INJECTIONS, SUBCUTANEOUS; LEUKEMIA, MYELOID, ACUTE; MALE; MIDDLE AGED; RECURRENCE; RETROSPECTIVE STUDIES; SALVAGE THERAPY; TREATMENT OUTCOME; YOUNG ADULT;

MLCS; MLOWN;

EID: 77449098778     PISSN: None     EISSN: 19380712     Source Type: Journal    
DOI: 10.3816/CLM.2009.n.058     Document Type: Article

References (0)